Arcus Biosciences President Sells $2 Million as Stock Delivers 48% Annual Return
Arcus BiosciencesArcus Biosciences(US:RCUS) The Motley Fool·2026-01-06 02:04

Arcus Biosciences, a clinical-stage oncology innovator, reported significant insider selling as its stock capped a strong one-year return.On Dec. 4, 2025, Juan C. Jaen, President of Arcus Biosciences (RCUS 6.53%), disposed of 82,997 shares in an open-market transaction via an indirect holding, generating a transaction value of 2,050,598accordingtotheSECForm4filing.TransactionsummaryMetricValueSharessold(indirect)82,997Transactionvalue 2,050,598 according to the SEC Form 4 filing.Transaction summaryMetricValueShares sold (indirect)82,997Transaction value~2.1 millionPost-transaction shares (direct)367,220Post-trans ...